Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF

NCT07630454 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

602

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Heart Failure With Preserved Ejection Fraction (HFpEF)
Tirzepatide

Interventions

DRUG: Tirzepatide
BEHAVIORAL: Structured Lifestyle Intervention

Sponsor

Yunlong Wang

Collaborators

[object Object]